Skip to main content

Table 4 Subgroup analyses for Gastrointestinal Neoplasms

From: Sarcopenia as a risk factor of progression-free survival in patients with metastases: a systematic review and meta-analysis

Cancer type

HR

95% CI

I2 (%)

No. studies

Colorectal

1.55

1.18 to 2.04

0

3

Gastric

1.36

0.49 to 3.74

85.5

2

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us